Science Explorer Back to mapMap

Most cited papers from Catalent (United States)

What are the most cited papers from Catalent (United States)?

The most cited paper from Catalent (United States) is "SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice" (Jing-Hui Tian et al., 2021), with 529 citations. Next come "Review and analysis of FDA approved drugs using lipid-based formulations" (226) and "The Science of USP 1 and 2 Dissolution: Present Challenges and Future Relevance" (125).

Showing 50 of 59 papers. Every paper with more than 16 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice Jing-Hui Tian et al. · Nature Communications Open access 14 Jan 2021 529
2 Review and analysis of FDA approved drugs using lipid-based formulations Ronak Savla, Jeff Browne, Vincent Plassat et al. · Drug Development and Industrial Pharmacy Open access 4 Jul 2017 226
3 The Science of USP 1 and 2 Dissolution: Present Challenges and Future Relevance Vivian A. Gray, Gregg Kelly, Min Xia et al. · Pharmaceutical Research 22 Jan 2009 125
4 Rational design of viscosity reducing mutants of a monoclonal antibody: Hydrophobic versus electrostatic inter-molecular interactions Pilarin Nichols, Li Li, Sandeep Kumar et al. · mAbs Open access 2 Jan 2015 118
5 Hot-Melt Extrusion: from Theory to Application in Pharmaceutical Formulation—Where Are We Now? Hemlata Patil, Sateesh Kumar Vemula, Sagar Narala et al. · AAPS PharmSciTech Open access 14 Feb 2024 104
6 Recent Developments in ADC Technology: Preclinical Studies Signal Future Clinical Trends Penelope M. Drake, David Rabuka · BioDrugs Open access 8 Nov 2017 102
7 Best Practices for Extractables and Leachables in Orally Inhaled and Nasal Drug Products: An Overview of the PQRI Recommendations Daniel L. Norwood, Diane Paskiet, Michael Ruberto et al. · Pharmaceutical Research 8 Jan 2008 91
8 CRISPR-Cas9 screens identify regulators of antibody–drug conjugate toxicity C. Kimberly Tsui, Robyn M. Barfield, Curt R. Fischer et al. · Nature Chemical Biology 26 Aug 2019 88
9 The seventh blind test of crystal structure prediction: structure generation methods Lily M. Hunnisett et al. · Acta Crystallographica Section B Structural Science Crystal Engineering and Materials Open access155 authors 13 Sep 2024 86
10 The seventh blind test of crystal structure prediction: structure ranking methods Lily M. Hunnisett et al. · Acta Crystallographica Section B Structural Science Crystal Engineering and Materials Open access147 authors 17 Oct 2024 80
11 Application of Film-Casting Technique to Investigate Drug–Polymer Miscibility in Solid Dispersion and Hot-Melt Extrudate Tapan Parikh, Simerdeep Singh Gupta, Anuprabha K. Meena et al. · Journal of Pharmaceutical Sciences 28 Apr 2015 80
12 Rapid Characterization of a Mechanically Labile α-Helical Protein Enabled by Efficient Site-Specific Bioconjugation Robert Walder, Marc-André LeBlanc, William J. Van Patten et al. · Journal of the American Chemical Society Open access 5 Jul 2017 77
13 Tandem-Cleavage Linkers Improve the In Vivo Stability and Tolerability of Antibody–Drug Conjugates Stepan Chuprakov, Ayodele O. Ogunkoya, Robyn M. Barfield et al. · Bioconjugate Chemistry Open access 9 Mar 2021 76
14 Structural basis for non-radical catalysis by TsrM, a radical SAM methylase Hayley L. Knox, Percival Yang-Ting Chen, Anthony J. Blaszczyk et al. · Nature Chemical Biology Open access 18 Jan 2021 73
15 Maytansine-bearing antibody-drug conjugates induce in vitro hallmarks of immunogenic cell death selectively in antigen-positive target cells Maxine Bauzon, Penelope M. Drake, Robyn M. Barfield et al. · OncoImmunology Open access 22 Jan 2019 70
16 Reconstitution of Formylglycine-generating Enzyme with Copper(II) for Aldehyde Tag Conversion Patrick G. Holder, Lesley Jones, Penelope M. Drake et al. · Journal of Biological Chemistry Open access 30 Apr 2015 69
17 Insights from native mass spectrometry approaches for top- and middle- level characterization of site-specific antibody-drug conjugates Thomas Botzanowski, Stéphane Erb, Oscar Hernandez‐Alba et al. · mAbs Open access 13 Apr 2017 66
18 Effect of carbamazepine on viscoelastic properties and hot melt extrudability of Soluplus ® Simerdeep Singh Gupta, Tapan Parikh, Anuprabha K. Meena et al. · International Journal of Pharmaceutics 17 Nov 2014 65
19 An emerging playbook for antibody–drug conjugates: lessons from the laboratory and clinic suggest a strategy for improving efficacy and safety Penelope M. Drake, David Rabuka · Current Opinion in Chemical Biology Review 2 Sep 2015 65
20 SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 elicits immunogenicity in baboons and protection in mice Jing-Hui Tian et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 30 Jun 2020 64
21 Extractables Characterization for Five Materials of Construction Representative of Packaging Systems Used for Parenteral and Ophthalmic Drug Products Dennis R. Jenke, Jessica Castner, Thomas Egert et al. · PDA Journal of Pharmaceutical Science and Technology Sep 2013 60
22 Formulation and development of pH-independent/dependent sustained release matrix tablets of ondansetron HCl by a continuous twin-screw melt granulation process Hemlata Patil, Roshan V. Tiwari, Sampada B. Upadhye et al. · International Journal of Pharmaceutics 11 Apr 2015 60
23 Equivalence Considerations for Orally Inhaled Products for Local Action—ISAM/IPAC-RS European Workshop Report Carole D. Evans et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery 13 Mar 2012 56
24 Poly(ADP-Ribose) Polymerases in Host-Pathogen Interactions, Inflammation, and Immunity Pamlea N. Brady, Anupam Goel, Margaret A. Johnson · Microbiology and Molecular Biology Reviews ReviewOpen access 3 Jan 2019 55
25 Cocrystallization via planetary milling: Enhancing throughput of solid-state screening methods Stephen R. Bysouth, J.A. Bis, David H. Igo · International Journal of Pharmaceutics 14 Apr 2011 54
26 Site-Specific Tandem Knoevenagel Condensation–Michael Addition To Generate Antibody–Drug Conjugates Romas A. Kudirka, Robyn M. Barfield, Jesse M. McFarland et al. · ACS Medicinal Chemistry Letters Open access 30 Aug 2016 52
27 The target product profile as a tool for regulatory communication: advantageous but underused Adria Tyndall, Wenny Du, Christopher D. Breder · Nature Reviews Drug Discovery Open access 17 Feb 2017 49
28 Generating aldehyde-tagged antibodies with high titers and high formylglycine yields by supplementing culture media with copper(II) Dona York, Jeanne Baker, Patrick G. Holder et al. · BMC Biotechnology Open access 24 Feb 2016 49
29 DATA CONFIDENTIALITY AND INTEGRITY: A REVIEW OF ACCOUNTING AND CYBERSECURITY CONTROLS IN SUPERANNUATION ORGANIZATIONS Anthony Chigozie Anyanwu, Temidayo Olorunsogo, Temitayo Oluwaseun Abrahams et al. · Computer Science & IT Research Journal Open access 21 Jan 2024 48
30 A Case Study to Identify the Drug Conjugation Site of a Site-Specific Antibody-Drug-Conjugate Using Middle-Down Mass Spectrometry Oscar Hernandez‐Alba, Stéphane Houel, Steve Hessmann et al. · Journal of the American Society for Mass Spectrometry 19 Aug 2019 41
31 CYBERSECURITY RISK ASSESSMENT IN BANKING: METHODOLOGIES AND BEST PRACTICES Samuel Onimisi Dawodu, Adedolapo Omotosho, Odunayo Josephine Akindote et al. · Computer Science & IT Research Journal Open access 24 Dec 2023 40
32 Digital inclusion initiatives: Bridging the connectivity gap in Africa and the USA – A review Benedicta Ehimuan, Anthony Chigozie Anyanwu, Temidayo Olorunsogo et al. · International Journal of Science and Research Archive Open access 26 Jan 2024 38
33 Histone Octamer Structure Is Altered Early in ISW2 ATP-Dependent Nucleosome Remodeling Arjan Hada, Swetansu K. Hota, Jie Luo et al. · Cell Reports Open access Jul 2019 35
34 Perfluorinated Alcohols Induce Complex Coacervation in Mixed Surfactants Samuel I. Jenkins, Christopher M. Collins, Morteza G. Khaledi · Langmuir 16 Feb 2016 35
35 Reconstitution and Purification of Nucleosomes with Recombinant Histones and Purified DNA Ilana M. Nodelman, Ashok Kumar Patel, Robert F Levendosky et al. · Current Protocols in Molecular Biology Open access Dec 2020 34
36 What’s the Regulatory Value of a Target Product Profile? Christopher D. Breder, Wenny Du, Adria Tyndall · Trends in biotechnology 6 Apr 2017 33
37 Effects of Device and Formulation on In Vitro Performance of Dry Powder Inhalers Wallace P. Adams, Sau L. Lee, Robert Plourde et al. · The AAPS Journal Open access 4 Apr 2012 33
38 Antibody-Drug Conjugates Targeting the Urokinase Receptor (uPAR) as a Possible Treatment of Aggressive Breast Cancer Efrat Harel, Penelope M. Drake, Robyn M. Barfield et al. · Antibodies Open access 5 Nov 2019 32
39 A rapid method for relative quantification of N -glycans from a therapeutic monoclonal antibody during trastuzumab biosimilar development Zaneer M. Segu, Todd A. Stone, Claudia Berdugo et al. · mAbs Open access 2020 30
40 Oral Cadmium in Mice Carrying 5 Versus 2 Copies of the Slc39a8 Gene Scott N. Schneider, Zhiwei Liu, Bin Wang et al. · International Journal of Toxicology Open access 17 Dec 2013 30
41 Exploratory studies in heat-assisted continuous twin-screw dry granulation: A novel alternative technique to conventional dry granulation Venkata Raman Kallakunta, Hemlata Patil, Roshan V. Tiwari et al. · International Journal of Pharmaceutics Open access 17 Nov 2018 29
42 CAT-02-106, a Site-Specifically Conjugated Anti-CD22 Antibody Bearing an MDR1-Resistant Maytansine Payload Yields Excellent Efficacy and Safety in Preclinical Models Penelope M. Drake, Adam Q. Carlson, Jesse M. McFarland et al. · Molecular Cancer Therapeutics Open access 15 Nov 2017 29
43 Evaluation of enzymatic and non‐enzymatic softening in low salt cucumber fermentations Rashmi Maruvada, Roger F. McFeeters · International Journal of Food Science & Technology 28 Apr 2009 26
44 Evaluation of Granulated Lactose as a Carrier for Dry Powder Inhaler Formulations 2: Effect of Drugs and Drug Loading Ping Du, Ju Du, Hugh D. C. Smyth · Journal of Pharmaceutical Sciences 8 Dec 2016 25
45 Development, evaluation of critical method variables and stability assessment using a Box–Behnken design for the determination of organic impurities in a pharmaceutical dosage form of a centrally acting muscle relaxant drug chlorzoxazone Santhosh Kumar Ettaboina, Satyasree Nannapaneni, Nagalakshmi Jeedimalla et al. · Biomedical Chromatography Open access 4 Sep 2024 24
46 Site-Specific Bioconjugation Using SMARTag® Technology: A Practical and Effective Chemoenzymatic Approach to Generate Antibody–Drug Conjugates Junjie Liu, Robyn M. Barfield, David Rabuka · Methods in molecular biology Book chapter 2019 24
47 Risk Management for Materials and Components Used in Orally Inhaled and Nasal Drug Products Cheryl L. M. Stults, Gaby Reckzuegel, Arthur W. Bailey et al. · Pharmaceutical Research 2 Sep 2015 23
48 Hydrophilic Sequence-Defined Cross-Linkers for Antibody–Drug Conjugates Joshua A. Walker, Michelle R. Sorkin, Francis Ledesma et al. · Bioconjugate Chemistry 31 Oct 2019 22
49 An effective and stability‐indicating method development and optimization utilizing the Box–Behnken design for the simultaneous determination of acetaminophen, caffeine, and aspirin in tablet formulation Parvateesam Yenda, Naresh Kumar Katari, Santhosh Kumar Ettaboina et al. · Biomedical Chromatography Open access 24 Jan 2023 21
50 QbD‐based stability‐indicating liquid chromatography (RP‐HPLC) method for the determination of flurbiprofen in cataplasm Rathnakar Nathi, Leela Prasad Kowtharapu, Siva Krishna Muchakayala et al. · Biomedical Chromatography 7 Jan 2023 21

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.